IRIS

Development of macrocyclic inhibitors of HCV NS3​/4A protease with cyclic constrained P2-​P4 linkers / Rudd, ; M, T.; Mcintyre, ; C, J.; Romano, ; J, J.; Butcher, ; J, W.; Holloway, ; M., K.; Bush, ; K, ; Nguyen, ; K, T.; Gilbert, ; K, F.; Lyle, ; T, A.; Liverton, ; N, J.; Wan, ; B-L, ; Summa, V; Harper, ; S, ; Rowley, ; M, ; Vacca, ; J, P.; Carroll, ; S, S.; Burlein, ; C, ; Dimuzio, ; J, M.; Gates, ; A, ; Graham, ; D, J.; Huang, ; Q, ; Ludmerer, ; S, W.; Mcclain, ; S, ; Mchale, ; C, ; Stahlhut, ; M, ; Fandozzi, ; C, ; Taylor, ; A, ; Trainor, ; N, ; Olsen, ; D, B.; Mccauley, ; J, A.. - In: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. - ISSN 0960-894X. - 22:23(2012), pp. 7207-7213.

Development of macrocyclic inhibitors of HCV NS3​/4A protease with cyclic constrained P2-​P4 linkers

Summa V;
2012
2012
Development of macrocyclic inhibitors of HCV NS3​/4A protease with cyclic constrained P2-​P4 linkers / Rudd, ; M, T.; Mcintyre, ; C, J.; Romano, ; J, J.; Butcher, ; J, W.; Holloway, ; M., K.; Bush, ; K, ; Nguyen, ; K, T.; Gilbert, ; K, F.; Lyle, ; T, A.; Liverton, ; N, J.; Wan, ; B-L, ; Summa, V; Harper, ; S, ; Rowley, ; M, ; Vacca, ; J, P.; Carroll, ; S, S.; Burlein, ; C, ; Dimuzio, ; J, M.; Gates, ; A, ; Graham, ; D, J.; Huang, ; Q, ; Ludmerer, ; S, W.; Mcclain, ; S, ; Mchale, ; C, ; Stahlhut, ; M, ; Fandozzi, ; C, ; Taylor, ; A, ; Trainor, ; N, ; Olsen, ; D, B.; Mccauley, ; J, A.. - In: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. - ISSN 0960-894X. - 22:23(2012), pp. 7207-7213.
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/774121
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 8
social impact